Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Assunta Manniello
Email: mariaassunta.manniello@hsanmartino.it
  P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

Short description of cell lines.
Species: mouse (all strains)


- By clicking on the cell line name, you will retrieve the detailed description of the cell line
- By clicking on one of the terms between parentheses, you will retrieve the list of all rilevant cell line

167.2 (connective) - ECBR
182.1 (connective) - ECBR
19X14 (connective) - ECBR
29.0.C.27 (connective) - ECBR
3611 MSV (4070A) (embryo) - NAUBP
3T3 (fibroblast) - DSMZ
3T3 (embryo) - ICLC
3T3 (embryo) - IZSBS
3T3 clone A31 (embryo) - ECACC
3T3 L1 (embryo) - ECACC
3T3 L1 (embryo) - IZSBS
3T3 NIH TK- (embryo) - MWIIW
3T3 Swiss Albino (embryo) - ECACC
3T3(+3) - ECACC
3T3-L1 (embryo) - MIECC
3T3-MSV (embryo) - ECACC
3T3-SV40 (embryo) - SPBIC
3T3-Swiss albino (embryo) - CHIBC
3T3-Swiss albino (embryo) - GEIAP
3T3-Swiss albino (embryo) - MIUBH
3T3-Swiss albino (embryo) - MIUEM
3T3-Swiss albino (embryo) - RMEBA
3T3-Swiss albino (embryo) - SPBIC
3T3B-SV40 (embryo) - SPBIC
3T6 (fibroblast) - DSMZ
3T6 (embryo) - IZSBS
3T6-Swiss Albino (embryo) - ECACC
3T6-Swiss albino (embryo) - SPBIC
416B (blood, leukemia) - ECACC
45.6.TG1.7 (myeloma) - ECACC
58D3C9 (connective) - ECBR
707 DAP10 (blood, leukemia, Friend) - ECACC
707B1011C3 (blood, leukemia, Friend) - ECACC
70Z/3 (blood, leukemia, pre-B cell) - ECACC
745C2 (blood, erythroleukemia, lymphoblast) - ECACC
9.0.4.C43 (connective) - ECBR
A11 (connective) - ECBR
A24 (connective) - ECBR
A7 (muscle, rhabdomyosarcoma) - SPBIC
A8/DI (thymoma) - ECACC
A8/DI (thymus, thymoma) - ICLC
A9 (areolar and adipose) - ECACC
A9 (areolar and adipose) - SPBIC
A9HT (areolar and adipose, carcinoma) - ECACC
AC2 (lymphoblast) - ECACC
AF-2 clone 9B5 (hybrid, B cells x myeloma, myeloma) - GEIBM
AF-2 clone 9B5 (hybrid, B cells x myeloma, myeloma) - ICLC
AKR-2B (embryo) - ECACC
AKR/11-D (thymus) - ICLC
AKR/12B-1 (thymus) - ICLC
AKR/12B-2 (thymus) - ICLC
AKR/12B-3 (thymus) - ICLC
AKR/13B (thymus) - ICLC
AKR/14C (thymus) - ICLC
Ampli-GPE (embryo) - ECACC
AtT-20/D16v-F2 (pituitary gland, pituitary tumor) - ECACC
AtT20 (pituitary tumor) - ECACC
B-63 (mammary gland, carcinoma) - IZSBS
B/C.Sk (skin, fibroblast) - ECACC
B104-1-1 (embryo) - ICLC
B16 melanoma 4A5 (skin, melanoma) - ECACC
B16-A (skin, melanoma) - BOUCN
B16-F0 (skin, melanoma) - ECACC
B16-F1 (melanoma) - CHIBC
B16-F1 (skin, melanoma) - ECACC
B16-F10 (melanoma) - CHIBC
B16-F10 (melanoma) - ICLC
B16V (skin, melanoma) - MIISB
B16VDxR (skin, melanoma) - MIISB
B18 (connective) - ECBR
B19 (connective) - ECBR
B2-1 (embryo) - IZSBS
B3/AN (thymus, thymoma) - ECACC
B3/AN (thymus, thymoma) - ICLC
B6/FA (thymus, thymoma) - ECACC
B78H1 (skin, melanoma) - BOUCN
B82 (areolar and adipose) - ECACC
B9 (spleen, hybridoma, B cell) - ECACC
B9 (hybrid, B cells x myeloma, hybridoma) - ICLC
BALB 3T12-3 (embryo) - IZSBS
BALB 3T3 clone A31 (embryo) - IZSBS
BALB/3T12-3 (embryo) - ECACC
BALB/3T3 clone A31 (embryo) - BOUCN
BALB/3T3 clone A31 (embryo) - ICLC
BALB/3T3 clone A31 (embryo) - MWIIW
BALB/3T3 clone A31 (embryo) - SPBIC
Balb/C MSV (AP129) (embryo) - NAUBP
BC3H1 (brain, tumor) - DSMZ
BC3H1 (brain, brain tumor) - ECACC
BC3H1 (brain, brain tumor) - IZSBS
BCL1 Clone CW13.20-3B3 (blood, leukemia, B cell) - ECACC
BL2-8G-E6 (connective) - ECBR
BLO-11 (muscle, hereditary emphysema) - ECACC
BNL CL.2 (liver, embryonic) - IZSBS
BNL SV A.8 (liver, embryonic) - IZSBS
BS1-B4 (embryo) - ECACC
BV-2 (brain, microglial cells) - ICLC
BW1J (liver, hepatoma) - ECACC
BW5147 (lymphoma, thymic) - MWIIW
BW5147.G.1.4.OUA/R.1 (blood, lymphoma) - ECACC
BW5147.G.1.4.OUAR.1 (blood, lymphoma, T cell) - ECACC
BWTG3 (liver, hepatoma) - SPBIC
C 108 (lung, carcinoma, Lewis lung) - RMICS
C 1271 (mammary gland, mammary tumor) - IZSBS
C127 - NAUBP
C127 ts - NAUBP
C127I (mammary gland, mammary tumor) - ECACC
C1300 CLONE NA (neural, neuroblastoma) - ECACC
C2C12 (muscle) - ECACC
C2C12 (muscle) - IZSBS
C2C12 (muscle) - SPBIC
C3H/10T1/2 clone 8 (embryo) - RMEBA
C3H/10T1/2 clone 8 (embryo) - SPBIC
C3H/MCA clone 16 (embryo) - ECACC
C57/B1 (skin, melanoma) - ECACC
C57SV (embryo) - BOUCN
C6/CH (thymus, thymoma) - ECACC
CCRF S 180 II (sarcoma) - IZSBS
CCRF S-180 II (sarcoma) - ECACC
CGR8 (embryo) - ECACC
CII3 (connective) - ECBR
CL-S1 (mammary alveolar nodules, preneoplastic) - ECACC
Clone 707 (blood, leukemia, Friend) - ECACC
Clone 707 (blood, leukemia, Friend) - ECACC
Clone M-3 (skin, melanoma) - ECACC
Clone M-3 (skin, melanoma) - IZSBS
CMT 93 (rectum, carcinoma) - ECACC
CMT 93 (rectum, carcinoma) - IZSBS
CMT64/61 (lung, carcinoma) - ECACC
CMT93/69 (rectum, carcinoma) - ECACC
CNC 127I (mammary gland, mammary tumor) - ECACC
COL-10 (mammary gland, carcinoma) - BOUCN
COL-7 (mammary gland, carcinoma) - BOUCN
CRE BAG2 (leukemia) - ECACC
CTLL-2 (lymphocyte, T) - ECACC
CTLL-2 (lymphocyte, T) - ICLC
D-36 (mast cell) - DSMZ
D10.G4.1 (lymphocyte, helper T) - DSMZ
D12/DM (thymus, thymoma) - ECACC
DA-1 (lymphoma) - DSMZ
DAP-3 DR1 (connective) - ECBR
DAP-3 DR4 (connective) - ECBR
DAP-3DPw2 (connective) - ECBR
DAP-3DQ1 (connective) - ECBR
DAP-3DR2a (connective) - ECBR
DAP-3DR2b (connective) - ECBR
DAP-3DRw52b (connective) - ECBR
DMBM-2 (macrophage) - DSMZ
DPW 5 (connective) - ECBR
DR 9 (connective) - ECBR
DS-G23 (haemopoietic, erythroleukemia) - NAUCC
DS19 (haemopoietic) - NAUCC
DS22-4 (haemopoietic) - NAUCC
E1 (mammary gland, carcinoma) - BOUCN
E1a (connective) - ECBR
E2 (mammary gland, carcinoma) - BOUCN
E3 (mammary gland, carcinoma) - BOUCN
E5ab2 (connective) - ECBR
Ehrlich-Lettre Ascites strain E (carcinoma, Ehrlich-Lettre ascites) - ECACC
EL4 (blood, lymphoma) - ECACC
EL4 (ascitic fluid, lymphoma, lymphoblastic) - PNIOS
EL4 (ascitic fluid, lymphoma, lymphoblastic) - SPBIC
EL4.BU.OU6 (blood, lymphoma, lymphoblastic) - ECACC
EL4.NOB-1 (blood, lymphoma, lymphoblastic) - ECACC
ELM-I-1 (erythroleukemia) - DSMZ
EPNT-5 (ependimoblastoma) - MWIIW
EPNT-5 (ependimoblastoma) - SPBIC
F1 (mammary gland, carcinoma) - BOUCN
F2 (mammary gland, carcinoma) - BOUCN
F4/4.K6 (lymphocyte, T) - DSMZ
F5 (mammary gland, carcinoma) - BOUCN
F9 (carcinoma, embryonal) - DSMZ
F9 (embryo, teratocarcinoma) - ECACC
F9 (testis, teratocarcinoma) - GEICV
F9 (testis, teratocarcinoma) - ICLC
F9 (testis, teratocarcinoma) - SPBIC
FLC clone 745 (erythroleukemia) - SPBIC
FLC clone M2 (erythroleukemia, Friend) - SPBIC
FM3A (breast, carcinoma) - ECACC
FM3Ats C1.T85 (breast, carcinoma) - ECACC
FS6 (skin, sarcoma) - CHIBC
G 26/24 (oligodendroglioma) - PAUBC
G-7 (muscle) - ECACC
G-7 (muscle) - IZSBS
G-8 (muscle) - ECACC
G.8 (muscle) - IZSBS
G/G (bladder) - DSMZ
GM86 Clone 745A (erythropoietic) - PGUPG
GPE 86 (kidney, embryonic) - ICLC
H2.35 (liver) - ECACC
HEPA 1-6 (liver, hepatoma) - DSMZ
Hepa 1-6 (liver, hepatoma) - ECACC
Hepa 1-6 (liver, hepatoma) - IZSBS
Hepa 1-clc7 (liver, hepatoma, BW7756) - ICLC
Hepa-1c1c7 (liver, hepatoma) - ECACC
Hepa-1clc7 (liver, hepatoma) - GEUCC
HII3 (connective) - ECBR
HSDM1C1 (fibrosarcoma) - ECACC
HSDM1C1 (fibrosarcoma) - IZSBS
HT2 Clone A5E (blood) - ECACC
I 10 (testis, Leydig cells, testicular tumor) - IZSBS
I-10 (testis, Leydig cells, testicular tumor) - ECACC
IC-21 (macrophage) - MIEOS
J 774A.1 (monocyte-macrophage, not defined tumor) - IZSBS
J-774 (sarcoma, histiocytic cell) - FEUPG
J-774 (sarcoma, histiocytic cell) - PDUBC
J-774A.1 (monocyte-macrophage, not defined tumor) - DSMZ
J26Cw3 (connective) - ECBR
J27.2 43R (connective) - ECBR
J27.2 Cw7neo (connective) - ECBR
J27.2 neoB7 (connective) - ECBR
J558L (blood, myeloma) - ECACC
J774.2 (blood, not defined tumor) - ECACC
J774A.1 (blood, not defined tumor) - ECACC
J774A.1 (monocyte-macrophage, monocyte-macrophage tumor) - ICLC
J774A.1 (monocyte-macrophage, not defined tumor) - MIECC
J774A.1 (monocyte-macrophage, not defined tumor) - PNIOS
JF5 (connective) - ECBR
JII1 (connective) - ECBR
JLS-V9 (bone marrow) - MWIIW
JRO1-27 (connective) - ECBR
K-BALB (K-234) (embryo) - ECACC
K129SV (kidney) - BOUCN
K2B-12H (connective) - ECBR
KB/cSV (kidney) - BOUCN
KCSV (kidney) - BOUCN
KD2SV (kidney) - BOUCN
KF1SV (kidney) - BOUCN
KLN 205 (carcinoma, squamous cell) - ECACC
KMP - IZSBS
L (fibroblast) - GEICH
L 1210 (ascitic fluid, leukemia, lymphocytic) - IZSBS
L 21.6 (hybrid, hybridoma) - IZSBS
L 929 (connective) - IZSBS
L-1210 (leukemia, lymphocytic) - DSMZ
L-929 (connective, fibroblast) - DSMZ
L-B7 (connective) - ECBR
L-DQw1-Dw12 (connective) - ECBR
L-DQw4-Dw15 (connective) - ECBR
L-DR2-Dw12 (connective) - ECBR
L-DR4-Dw15 (connective) - ECBR
L-DRw53-Dw15 (connective) - ECBR
L-HSO2 (connective) - ECBR
L-M (connective) - ECACC
L-M (TK-) (connective) - ECACC
L-M(TK-) (connective) - MWIIW
L-M(TK-,APRT-) (connective) - SPBIC
L/neo (connective) - ECBR
L105.1 (connective) - ECBR
L11.3 (connective) - ECBR
L12.2 (connective) - ECBR
L1210 (blood, leukemia, lymphocytic) - ECACC
L1210 (ascitic fluid, leukemia, lymphocytic) - ICLC
L1210 (ascitic fluid, leukemia, lymphocytic) - MIILC
L1210 (ascitic fluid, leukemia, lymphocytic) - MIUCC
L1210 (ascitic fluid, leukemia, lymphocytic) - SPBIC
L138.8A (bone marrow, mast cells) - DSMZ
L164.11 (connective) - ECBR
L165.6 (connective) - ECBR
L166.1 (connective) - ECBR
L168.2 (connective) - ECBR
L17.8 (connective) - ECBR
L201.15 (connective) - ECBR
L21.3 (connective) - ECBR
L25.4 (connective) - ECBR
L3.6.2 (connective) - ECBR
L5178Y (thymus, lymphoma, thymic) - ECACC
L5178Y-R (LY-R) (thymus, lymphoma, thymic) - ECACC
L5178Y-S (LY-S) (thymus, lymphoma, thymic) - ECACC
L54.5 (connective) - ECBR
L57.23 (connective) - ECBR
L89.2 (connective) - ECBR
L91.7 (connective) - ECBR
L929 (areolar and adipose) - ECACC
L929 (connective) - ICLC
L929 (connective) - MIUCC
L929(NCTC) (areolar and adipose) - ECACC
L929S (areolar and adipose) - ECACC
LA-4 (lung, adenoma) - ECACC
LA32mHC2 (connective) - ECBR
LAP 4108-6 (connective) - ECBR
LAQ 8251 (connective) - ECBR
LARB1 1212 (connective) - ECBR
LAT 1 (connective) - GEIMG
LAT II (connective) - GEIMG
LB72mC25 (connective) - ECBR
LBRM-33-1A5 (blood, lymphoma) - ECACC
LDR+25 (connective) - ECBR
LDR2A (connective) - ECBR
LDR2B (connective) - ECBR
LDR7 (connective) - ECBR
LDR8 (connective) - ECBR
LEII (lung, endothelium) - BSUPG
Line 14 (connective) - ECBR
LL/2(LLc1) (lung, carcinoma, Lewis lung) - ECACC
LM from NCTC clone 929 (connective) - IZSBS
LM TK negative (connective) - IZSBS
LPP 3-6 (connective) - ECBR
LPRB3 112 (connective) - ECBR
LR3.1/3 (connective) - ECBR
LR6.2/52a (connective) - ECBR
LR6.3/52C (connective) - ECBR
LS1 (connective) - SPBIC
LTK- (connective) - ECACC
LTK- (connective) - ICLC
M 1 (bone marrow, leukemia, myeloid) - IZSBS
M-MSV-BALB/3T3 (embryo) - BOUCN
M-MSV-BALB/3T3 (embryo) - ECACC
M. dunni (Clone III8C) (tail) - ECACC
M1 (myeloblast, leukemia, myeloid) - ECACC
M1 (skin, leukemia, myeloid) - ECACC
M15 (mesonephros) - ECACC
M3 Clone M-3 (skin, melanoma) - ECACC
M4 (lung nodule, sarcoma) - CHIBC
M5076 (sarcoma, reticulum cell) - CHIBC
M8 (lung, sarcoma) - CHIBC
M9 (lung nodule, sarcoma) - CHIBC
Mab 62B1-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
Mab 8A-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
Mab 8F6-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
MADISON LUNG TA-109 (lung, carcinoma) - MIEOS
MB-III (de Bruyn Grey) (lymph, lymphosarcoma) - ECACC
Mc Coy - IZSBS
Mc Coy - PRUMB
MC3T3-E1 (fibroblast, embryonic) - DSMZ
McCoy - ECACC
MCH-7 (MX-7) (muscle, rhabdomyosarcoma) - SPBIC
MCH-82 (MX-82) (muscle, rhabdomyosarcoma) - SPBIC
MELC (erythroleukemia) - MIISB
MELC DR10 (erythroleukemia) - MIISB
MELC DS19 (erythroleukemia) - MIISB
Meta 10 (lung, metastasis, cancer) - ECACC
Meta 15 (lung, metastasis, cancer) - ECACC
Meta 7 (lung, metastasis, cancer) - ECACC
META-1 (mammary gland, carcinoma) - BOUCN
META-10 (lung, metastasis, cancer) - BOUCN
META-7 (lung, metastasis, cancer) - BOUCN
mFS6 (lung nodule, sarcoma) - CHIBC
MG-1361 (mammary gland, adenocarcinoma) - ICLC
MH-22A (liver, carcinoma, hepatocellular) - ECACC
MH-22a (liver, hepatoma) - SPBIC
MH-S (macrophage) - ECACC
MH-S (lung) - IZSBS
MLg (lung) - ECACC
MMT-060562 (breast, mammary tumor) - ECACC
MOP-8 (embryo) - ECACC
MOPC 315 (myeloma) - ECACC
MOPC 31C (plasmacytoma) - ECACC
MOUSE L CELLS (TK+, HBS Ag+) (skin) - ECACC
MPC-11 (blood, myeloma) - ECACC
MPC-11 (myeloma) - IZSBS
MRSV (AP170) (fibroblast) - NAUBP
MSV.B (fibroblast, embryonic) - ECACC
MSVIF-TK+ (embryo) - ECACC
MTP-GFP (mammary gland, adenocarcinoma) - ICLC
N-18 (neuroblastoma) - PACBC
N18TG2 (neuroblastoma) - DSMZ
N1E-115 (nervous system, neuroblastoma) - ECACC
N1E-115 (neuroblastoma) - PACBC
N4TG3 (neuroblastoma) - DSMZ
NA C 1300 clone (brain, neuroblastoma) - IZSBS
NB4 1A3 (nervous system, neuroblastoma) - ECACC
NB41A3 (neuroblastoma) - SPBIC
NCTC 2071 (connective) - ECACC
NCTC 3749 (lymph, lymphoid neoplasm) - ECACC
NCTC 4093 (embryo) - ECACC
NCTC clone 1469 (liver) - ECACC
NCTC clone 2472 (connective) - ECACC
NCTC clone 2555 (connective) - ECACC
NCTC clone 929 (connective) - ECACC
NCTC clone 929 (connective) - MWIIW
NCTC clone 929 (connective) - SIUCC
NCTC clone 929 (connective) - SPBIC
Neuro 2a (neuroblastoma) - ECACC
NEURO-2A (neuroblastoma) - DSMZ
Neuro-2A (neuroblastoma) - ICLC
Neuro-2a (neuroblastoma) - IZSBS
Neuro-2a (neuroblastoma) - NAUBC
Neuro-2a (neuroblastoma) - SPBIC
NFS-25 C-3 (lymphoblast, pre-B, lymphoma, lymphoblastic) - ECACC
NFS-5 C1 (lymphoma) - ECACC
NFS-70 C10 (lymphoma) - ECACC
NIH 3T3 (embryo) - ECACC
NIH 3T3 (embryo) - ICLC
NIH EGFR-T17 (embryo) - MIUBH
NIH-3T3 (embryo) - DSMZ
NIH-3T3 4-2 (embryo) - ECACC
NIH-3T3D4 (embryo) - ECACC
NIH/3T3 (embryo) - BGEBS
NIH/3T3 (embryo) - CHIBC
NIH/3T3 (embryo) - MIUBH
NIH/3T3 (embryo) - MWIIW
NIH/3T3 (embryo) - NAUBP
NIH/3T3 (embryo) - PNIOS
NIH/3T3 (embryo) - SPBIC
NMU (lung, carcinoma) - MIISB
NMuMG (mammary gland) - ECACC
NOR 10 (muscle) - ECACC
NOR 10 (muscle) - IZSBS
NP (myeloma) - MWIIW
NS0 (myeloma) - ECACC
NS0/1 (myeloma) - MWIIW
NS0/1 (myeloma) - SPBIC
NS20Y (neuroblastoma) - DSMZ
NSO (myeloma) - IZSBS
NSO (myeloma) - PNIOS
NUC-1 (bladder) - DSMZ
NUC-5 (bladder) - DSMZ
NULLI-SCC1 (testis, teratocarcinoma) - GEICV
NULLI-SCC1 (testis, teratocarcinoma) - ICLC
OMEGA-E (embryo) - DSMZ
P-815 (mastocytoma) - DSMZ
P-815 (mastocytoma) - SPBIC
P1.HTR - ECACC
P1.HTR.TK- (mastocytoma) - ECACC
P19 (teratocarcinoma) - ECACC
P19 (embryo, teratocarcinoma) - ICLC
P1Bb1.1 (DBA/2) (mastocytoma) - ECACC
P3 88 D1 (monocyte-macrophage, lymphoma) - IZSBS
P3 NS1 Ag4 (myeloma) - IZSBS
P3/NS1/1-Ag4-1(NS-1) (myeloma) - MWIIW
P3/NS1/1-Ag4-1(NS-1) (myeloma) - PNIOS
P3/NS1/1-Ag4-1(NS-1) (myeloma) - SPBIC
P3/NS1/1-Ag4.1 (myeloma) - ECACC
P3/NSI/1-AG4-1 (myeloma) - DSMZ
P388 (blood, leukemia) - MIISB
P388.D1 (Clone 3124) (lymphoid neoplasm) - ECACC
P388.D1 (clone 3124) (lymphoid, lymphoid neoplasm) - ICLC
P388/DX (leukemia) - MIISB
P388D1 (lymphoid neoplasm) - SPBIC
P388D1 (IL-1) (monocyte-macrophage, lymphoma) - MIECC
P3U1 (myeloma) - ECACC
P3X63Ag8 (myeloma) - ECACC
P3X63Ag8 (lymphoblast, myeloma) - ICLC
P3X63Ag8 (myeloma) - MWIIW
P3X63Ag8.653 (myeloma) - ECACC
P3X63Ag8.653 (myeloma) - MWIIW
P3X63Ag8.653 (myeloma) - PACBC
P3X63Ag8.653 (myeloma) - SPBIC
P3X63Ag8U.1 (plasmacytoma) - ECACC
P3X63Ag8U.1 (plasmacytoma) - GEIAP
P3X63Ag8U.1 (plasmacytoma) - GEIIB
P3X63Ag8U.1 (myeloma) - ICLC
P815 (mastocytoma) - IZSBS
P815-1-1 (mastocytoma) - ECACC
PA317 (fibroblast) - ECACC
PA317 (embryo) - ICLC
PA317 (fibroblast) - SPBIC
PB-1 (pre B cell) - DSMZ
PCC4 aza1 (testis, teratocarcinoma) - SPBIC
PEA-10 (fibroblast, embryonic) - ECACC
PG13 (fibroblast, embryonic) - ECACC
PI1 (connective) - ECBR
PSA1 (embryo, teratocarcinoma) - ECACC
PSA1-NG2 (embryo, teratocarcinoma) - ECACC
PSI 2 BAG alpha (embryo) - SPBIC
PSI-2 (embryo) - DSMZ
Psi-CRE - ECACC
Psi-CRIP - ECACC
PSM-B (teratocarcinoma) - ECACC
Pu-518 (lymphoid neoplasm) - ECACC
Py 1-18 MuLV (embryo) - NAUBP
R/3.2-L (connective) - ECBR
R/R1H-L (connective) - ECBR
RAG (kidney, adenocarcinoma) - CHIBC
RAG (kidney, adenocarcinoma) - ECACC
RAG (kidney, adenocarcinoma) - MWIIW
RAW 264 (ascitic fluid, leukemia, monocytic-macrophage) - ECACC
RAW 264.7 (ascitic fluid, leukemia, monocytic-macrophage) - ECACC
RAW 264.7 (macrophage) - ICLC
RED.1 (erythroleukemia) - ECACC
RVP3 (sarcoma) - MWIIW
S13ba3 (connective) - ECBR
SC-1 (embryo) - ECACC
SC-1 (embryo) - ICLC
SC-1 (F1701 clone 1116A) (fibroblast, embryonic) - MWIIW
Sp2/0-Ag14 (hybrid, myeloma) - ANIIR
SP2/0-Ag14 (hybrid, myeloma) - ECACC
Sp2/0-Ag14 (hybrid, myeloma) - MWIIW
Sp2/0-Ag14 (hybrid, myeloma) - SPBIC
SR-4987 (bone marrow, stromal cells) - ECACC
SR-4987 (bone marrow, stromal cells) - ICLC
SR4987 (bone marrow, stromal cells) - MIUCC
STO (embryo) - ANIIR
STO (fibroblast, embryonic) - ECACC
STO (embryo) - IZSBS
Subclone 707 BUF (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DAP8 (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DK 4.8 (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DKA (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DKE (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DKH (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 DKJ (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 TG1 (lymphoblast, leukemia, Friend) - ECACC
Subclone 707 TG2 (lymphoblast, leukemia, Friend) - ECACC
SV-T2 (embryo) - BOUCN
SV-T2 (embryo) - ECACC
SV-T2 (embryo) - IZSBS
SV3T3 (fibroblast) - GEICH
SV3T3B (embryo) - ECACC
Swiss-3T3 (embryo) - MIISB
TA3 Hauschka (mammary gland, carcinoma) - ECACC
TCMK-1 (kidney) - ECACC
TGP 49 (pancreas, carcinoma) - ECACC
TGP 52 (pancreas, islet tumor) - ECACC
TGP 54 (pancreas, islet tumor) - ECACC
TGP 55 (pancreas, carcinoma) - ECACC
TK-LM clone 1D (connective) - MWIIW
TM 902 (lymphocyte) - ECBR
TM 903 (lymphocyte) - ECBR
TM3 (testis, Leydig cells) - ECACC
TM4 (testis, Sertoli cell) - ECACC
TR6.1/52b (connective) - ECBR
TR6Bc1 (brain, schwannoma) - ECACC
TS/A (mammary gland, carcinoma) - BOUCN
WEHI 164 (fibrosarcoma) - ECACC
WEHI 164 (fibrosarcoma) - SPBIC
WEHI 3B (leukemia, myelomonocytic) - ECACC
WEHI 3B (leukemia, myelomonocytic) - NAUBP
WEHI 3BD (leukemia, granulocytic or myelocytic) - ECACC
WEHI-164 (fibrosarcoma) - ICLC
WEHI-164S (fibrosarcoma) - DSMZ
WEHI-231 (lymphoma, lymphoblastic) - ECACC
WEHI-274.1 (monocyte tumor) - ECACC
WEHI-279 (lymphoma) - ECACC
WEHI-3 (monocyte, leukemia, monocytic) - SPBIC
WEHI-3B (leukemia, myelomonocytic) - DSMZ
WEHI-3B (monocyte, leukemia, myelomonocytic) - ICLC
WEHI-3B(D+) (leukemia, granulocytic or myelocytic) - MIUCC
WEHI-3B/CPX (monocyte, leukemia, myelomonocytic) - ICLC
Wgd5 - ECACC
WOP (embryo) - ICLC
WX310 (unspecified tissue) - ECACC
X63AG8.653 (myeloma) - DSMZ
Y 1 (adrenal cortex, adrenal tumor) - IZSBS
Y-1 (adrenal cortex, adrenal tumor) - MIUCC
Y-1 (adrenal cortex, adrenal tumor) - MWIIW
Y1 (adrenal cortex, adrenal tumor) - ECACC
YAC-1 (lymphoma) - ANIIR
YAC-1 (lymphoma) - DSMZ
YAC-1 (lymphoma) - ECACC
YAC-1 (lymphoma) - SPBIC


For information, get in touch with:
IRCCS AOU San Martino IST,
c/o Centro Biotecnologie Avanzate, Torre D - Piano 2

Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Assunta Manniello
Email: mariaassunta.manniello@hsanmartino.it

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105